Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases

Early induction of functional SARS-CoV-2 specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients

(2021) Anthony T. Tan et al.   Cell Reports

Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans

(2021) Alberto Cagigi et al.   Vaccines

Thrombocytopenia following Pfizer and Moderna SARS‐CoV ‐2 vaccination

(2021) Eun‐Ju Lee et al.   AMERICAN JOURNAL OF HEMATOLOGY

SARS-CoV-2 Vaccines

(2021) C. Buddy Creech et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Safety of Recombinant Zoster Vaccine: a Retrospective Study of 622 Rheumatology Patients

(2021) Tiphaine Lenfant et al.   RHEUMATOLOGY

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2021

(2021) Mark S. Freedman et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond

(2021) Emily Bettini et al.   Vaccines

Impact of Biological Therapies on the Immune Response after Pneumococcal Vaccination in Patients with Autoimmune Inflammatory Diseases

(2021) Patricia Richi et al.   Vaccines

Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases

(2021) Brian J Boyarsky et al.   ANNALS OF THE RHEUMATIC DISEASES

SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response

(2021) Michael Markus Bonelli et al.   ANNALS OF THE RHEUMATIC DISEASES

Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases

(2021) Robert Spiera et al.   ANNALS OF THE RHEUMATIC DISEASES

Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort

(2021) Ulf M Geisen et al.   ANNALS OF THE RHEUMATIC DISEASES

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination

(2021) Nina H. Schultz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

(2021) Andreas Greinacher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

(2021) Jerald Sadoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)

(2021) Kerry J. Welsh et al.   VACCINE

American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients with Rheumatic and Musculoskeletal Diseases – Version 1

(2021) Jeffrey R Curtis et al.   Arthritis & Rheumatology

Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination

(2021) Abdulla Watad et al.   Vaccines

Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease

(2021) Rebecca H Haberman et al.   ANNALS OF THE RHEUMATIC DISEASES

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021

(2021) Julia W. Gargano et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military

(2021) Jay Montgomery et al.   JAMA Cardiology

Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination

(2021) Han W. Kim et al.   JAMA Cardiology

Recommended Adult Immunization Schedule, United States, 2020*

(2020) Mark Freedman et al.   ANNALS OF INTERNAL MEDICINE

Methotrexate and its mechanisms of action in inflammatory arthritis

(2020) Bruce N. Cronstein et al.   Nature Reviews Rheumatology

Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2–5 years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept

(2020) Hermine I. Brunner et al.   Pediatric Rheumatology

Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs

(2020) Georgina Nakafero et al.   RHEUMATOLOGY

Pneumococcal antibody protection in patients with autoimmune inflammatory rheumatic diseases with varying vaccination status

(2020) SL Rasmussen et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

High dose trivalent influenza vaccine compared to standard dose vaccine in patients with rheumatoid arthritis receiving TNF-alpha inhibitor therapy and healthy controls: Results of the DMID 10-0076 randomized clinical trial

(2020) Jack T. Stapleton et al.   VACCINE

Safety and immunogenicity of a primary yellow fever vaccination under low-dose methotrexate therapy—a prospective multi-centre pilot study1

(2020) Silja Bühler et al.   JOURNAL OF TRAVEL MEDICINE

Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with childhood systemic lupus erythematosus: a real-world interventional multi-centre study

(2020) Ingrid Herta Rotstein Grein et al.   LUPUS

Autoimmune and inflammatory diseases following COVID-19

(2020) Caroline Galeotti et al.   Nature Reviews Rheumatology

Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials

(2020) Alemnew F Dagnew et al.   RHEUMATOLOGY

Do immunosuppressive agents hamper the vaccination response in patients with rheumatic diseases? A review of the literature

(2020) Dorra Ben Nessib et al.   THERAPIE

High Immunogenicity to Influenza Vaccination in Crohn’s Disease Patients Treated with Ustekinumab

(2020) Laura Doornekamp et al.   Vaccines

COVID-19 and autoimmune diseases

(2020) Yu Liu et al.   CURRENT OPINION IN RHEUMATOLOGY

Psoriasis flare after influenza vaccination in Covid‐19 era: A report of four cases from a single center

(2020) Pablo Munguía‐Calzada et al.   Dermatologic Therapy

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

(2020) Merryn Voysey et al.   LANCET

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Selective Janus kinase inhibitors come of age

(2019) John J. O’Shea et al.   Nature Reviews Rheumatology

High dose hepatitis B vaccine is not effective in patients using immunomodulatory drugs: a pilot study

(2019) Asli Haykir Solay et al.   Human Vaccines & Immunotherapeutics

Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases—a prospective multi-centre cohort study

(2019) S Bühler et al.   RHEUMATOLOGY

The immunogenicity of seasonal and pandemic influenza vaccination in autoimmune inflammatory rheumatic patients—a 6-month follow-up prospective study

(2019) K. Lakota et al.   CLINICAL RHEUMATOLOGY

Antibody responses to influenza vaccine in patients on biological therapy: Results of RIER cohort study

(2019) Patricia Richi et al.   MEDICINA CLINICA

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

(2019) Victoria Furer et al.   ANNALS OF THE RHEUMATIC DISEASES

Immunogenicity and safety of vaccination against seasonal influenza vaccine in patients with psoriatic arthritis treated with secukinumab

(2019) Victoria Furer et al.   VACCINE

Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial

(2018) Jin Kyun Park et al.   ANNALS OF THE RHEUMATIC DISEASES

Lower Sustained Diphtheria and Pertussis Antibody Concentrations in Inflammatory Bowel Disease Patients

(2018) Freddy Caldera et al.   DIGESTIVE DISEASES AND SCIENCES

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

(2018) Norah A. Terrault et al.   HEPATOLOGY

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

(2018) Anthony L Cunningham et al.   JOURNAL OF INFECTIOUS DISEASES

T-cell–mediated immune response to pneumococcal conjugate vaccine (PCV-13) and tetanus toxoid vaccine in patients with moderate-to-severe psoriasis during tofacitinib treatment

(2018) Kevin L. Winthrop et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The effect of immunosuppressive agents on immunogenicity of pneumococcal vaccination: A systematic review and meta-analysis

(2018) Mariëlle van Aalst et al.   VACCINE

Interaction between B-cell activation factor and methotrexate impacts immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis

(2018) Jin Kyun Park et al.   ANNALS OF THE RHEUMATIC DISEASES

Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine

(2017) Meliha C. Kapetanovic et al.   VACCINE

Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodies

(2017) Janie Parrino et al.   VACCINE

The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial

(2017) Kevin L. Winthrop et al.   Arthritis & Rheumatology

Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept

(2016) Rieke Alten et al.   BMC MUSCULOSKELETAL DISORDERS

The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis

(2015) Kevin L Winthrop et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

(2015) Himal Lal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immunogenicity and safety of the human papillomavirus vaccine in patients with autoimmune diseases: A systematic review

(2015) Paolo Pellegrino et al.   VACCINE

Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: Data from the international COMORA cohort

(2015) Ihsane Hmamouchi et al.   VACCINE

Risks of Herpes Zoster in Patients With Rheumatoid Arthritis According to Biologic Disease-Modifying Therapy

(2015) Huifeng Yun et al.   ARTHRITIS CARE & RESEARCH

Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases – a longitudinal study

(2015) Lara Fischer et al.   ARTHRITIS RESEARCH & THERAPY

Seroconversion in Patients With Rheumatic Diseases Treated With Immunomodulators or Immunosuppressants, Who Were Inadvertently Revaccinated Against Yellow Fever

(2015) Ana C. V. Oliveira et al.   Arthritis & Rheumatology

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

(2015) Jasvinder A. Singh et al.   Arthritis & Rheumatology

Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study

(2014) Seoyoung C Kim et al.   ANNALS OF THE RHEUMATIC DISEASES

Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA)

(2014) Clifton O Bingham et al.   ANNALS OF THE RHEUMATIC DISEASES

Increased risk of high grade cervical squamous intraepithelial lesions in systemic lupus erythematosus: A meta-analysis of the literature

(2014) Emilie Zard et al.   AUTOIMMUNITY REVIEWS

Should we target patients with autoimmune diseases for human papillomavirus vaccine uptake?

(2014) Candace H Feldman et al.   Expert Review of Vaccines

Immunogenicity and safety of the bivalent HPV vaccine in female patients with juvenile idiopathic arthritis: a prospective controlled observational cohort study

(2013) Marloes W Heijstek et al.   ANNALS OF THE RHEUMATIC DISEASES

The effect of rituximab on vaccine responses in patients with immune thrombocytopenia

(2013) I. Nazi et al.   BLOOD

Immunogenicity and Tolerability to Human Papillomavirus-like Particle Vaccine in Girls and Young Women with Inflammatory Bowel Disease

(2013) Denise L. Jacobson et al.   INFLAMMATORY BOWEL DISEASES

Immune response to influenza vaccine and pneumococcal polysaccharide vaccine under IL-6 signal inhibition therapy with tocilizumab

(2013) Tomomi Tsuru et al.   Modern Rheumatology

Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults

(2013) Stéphanie Pépin et al.   VACCINE

Safety and Immunogenicity of Yellow Fever 17D Vaccine in Adults Receiving Systemic Corticosteroid Therapy: An Observational Cohort Study

(2013) Solen Kernéis et al.   ARTHRITIS CARE & RESEARCH

Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

(2013) Charlotte Hua et al.   ARTHRITIS CARE & RESEARCH

Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis

(2013) Meliha Crnkic Kapetanovic et al.   ARTHRITIS RESEARCH & THERAPY

Efficacy of Hepatitis B Vaccination and Revaccination and Factors Impacting on Response in Patients With Inflammatory Bowel Disease

(2012) J P Gisbert et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case–control study

(2012) Chi Chiu Mok et al.   ANNALS OF THE RHEUMATIC DISEASES

Anti-TNF treatment blocks the induction of T cell-dependent humoral responses

(2012) Gabriela Franco Salinas et al.   ANNALS OF THE RHEUMATIC DISEASES

Development and validation of a risk score for serious infection in patients with rheumatoid arthritis

(2012) Cynthia S. Crowson et al.   ARTHRITIS AND RHEUMATISM

Treatment with the Interleukin-17A-Blocking Antibody Secukinumab Does Not Interfere with the Efficacy of Influenza and Meningococcal Vaccinations in Healthy Subjects: Results of an Open-Label, Parallel-Group, Randomized Single-Center Study

(2012) A. Chioato et al.   Clinical and Vaccine Immunology

Association Between Vaccination for Herpes Zoster and Risk of Herpes Zoster Infection Among Older Patients With Selected Immune-Mediated Diseases

(2012) Jie Zhang et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

TNF blockers show distinct patterns of immune response to the pandemic influenza A H1N1 vaccine in inflammatory arthritis patients

(2012) I. L. A. Franca et al.   RHEUMATOLOGY

Abatacept and reduced immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritis

(2012) Ana C. Ribeiro et al.   ARTHRITIS CARE & RESEARCH

Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors

(2011) Meliha Crnkic Kapetanovic et al.   ARTHRITIS AND RHEUMATISM

High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: A long-term followup study in a Danish cohort

(2011) Lene Dreyer et al.   ARTHRITIS AND RHEUMATISM

Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases

(2011) P. Engel et al.   PHARMACOLOGICAL REVIEWS

Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study

(2011) S. Adler et al.   RHEUMATOLOGY

The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab

(2011) U. Arad et al.   VACCINE

The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study

(2011) Jie Zhang et al.   ARTHRITIS RESEARCH & THERAPY

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

(2010) S. van Assen et al.   ANNALS OF THE RHEUMATIC DISEASES

Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: a systematic review

(2010) Iuri Usêda Santana et al.   CLINICAL RHEUMATOLOGY

Yellow fever revaccination during infliximab therapy

(2010) Morton Scheinberg et al.   ARTHRITIS CARE & RESEARCH

Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment

(2010) Maria Rehnberg et al.   ARTHRITIS RESEARCH & THERAPY

Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial

(2009) Clifton O. Bingham et al.   ARTHRITIS AND RHEUMATISM

Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab

(2009) Sander van Assen et al.   ARTHRITIS AND RHEUMATISM

The Effect of Infliximab and Timing of Vaccination on the Humoral Response to Influenza Vaccination in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis

(2009) Ori Elkayam et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Vaccines: Vaccination in Patients with Chronic Rheumatic or Autoimmune Diseases

(2008) T. Glück et al.   CLINICAL INFECTIOUS DISEASES

Higher Incidence of Abnormal Pap Smears in Women With Inflammatory Bowel Disease

(2007) Sunanda Kane et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY